National Law Review September 27, 2021

Over the past year, the federal government has taken concrete steps to fulfill its promise of a heightened commitment to investigating and enforcing health care fraud within the Medicare Advantage program (Medicare Part C). Health care providers that contract with Medicare Advantage Organizations (“MAOs”) and provide care to Medicare Advantage beneficiaries should take note, as they are not immune to the government’s enforcement efforts. Across two speeches in 2020, the Department of Justice (“DOJ”) identified Medicare Part C as a program of increasing focus and an important priority for False Claims Act (“FCA”) investigations and litigation. There are a growing number of recent decisions by DOJ to intervene in FCA cases alleging Medicare Advantage fraud, and a growing number of...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Govt Agencies, Insurance, Medicare, Medicare Advantage, Payer, Provider
A Medicare Advantage fix: What took so long?
New Report Identifies Potential Reforms to the Medicare Advantage Quality Bonus Program That Could Save Up to $108 billion
The Basics of Risk Adjustment
Gaps in Medicare Advantage Data Remain Despite CMS Actions to Increase Transparency
Final rule issues guardrails in compensation to agents and brokers

Share This Article